1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. Pennsylvania >
  6. Zynerba Pharmaceuticals

Zynerba Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Zynerba Pharmaceuticals Ownership

Who owns Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals is owned by Harmony Biosciences. It was acquired on August 14, 2023.

Zynerba Pharmaceuticals Business Overview

Where is Zynerba Pharmaceuticals headquartered?

Zynerba Pharmaceuticals is headquartered in Devon, Pennsylvania.

How many employees does Zynerba Pharmaceuticals have?

Zynerba Pharmaceuticals has 25 employees.

What sector is Zynerba Pharmaceuticals in?

Zynerba Pharmaceuticals is a life science company.

When was Zynerba Pharmaceuticals founded?

Zynerba Pharmaceuticals was founded in 2007.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Subscribe to Mergr to view all 212 acquisitions of life science companies in 2023, including 28 acquisitions by private equity firms, and 184 by strategics.

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals, Inc.

80 West Lancaster Avenue Suite 300,
Devon, Pennsylvania 19333
United States,
(484) 581-7505
www.zynerba.com

Zynerba Pharmaceuticals is a pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, including Fragile X syndrome (FXS). Zynerba Pharmaceuticals was founded in 2007 and is based in Devon, Pennsylvania.


Company Summary

SECTOR

Life Science

Employees

25

Established

2007

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Zynerba Pharmaceuticals

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal